Jump to content

Digitalization Fuels Innovation in Vaccine Research

Festival of Biologics
October 9, 2023

The unprecedented speed and innovation involved in pandemic vaccine development re-set industry norms and public expectations for next-generation vaccines such as mRNA and virus-based formats. Digital technologies proved invaluable in these efforts and remain the key to shorten timelines, lower costs, and boost innovation. The Genedata E2E knowledge management platform automates and scales up vaccine research, discovery, and process development and covers all vaccine formats and serotypes. Acting as a central digital workflow backbone, the platform ensures data integrity, enables maximum automation, and serves as an essential structured data foundation for AI/ML and digital data modeling to further revolutionize vaccine R&D. In this poster, we spotlight Genedata Biologics® and focus on vaccine research, including vaccine design, molecular biology, vaccine expression, purification, and characterization.

Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy